NBY News and Press, NovaBay Pharmaceuticals Inc. From 03/08/21

NovaBay Pharmaceuticals (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova ® for the eye care market and CelleRx ® Clinical Reset™ for the beauty market, announces that management will hold one-on-one investor meetings at the Virt...

No matter how you break up your portfolio, you may want to set aside a potion for small-cap penny stocks. The main reason for that: small-caps are far-outperforming the broader markets. If you take a look at benchmark ETFs like the S&P SPY, the Nasdaq QQQ, and the Russell Small-Cap IWM,...

Issuing a letter to investors, NovaBay Pharmaceuticals (NBY) said that the current liquidity level of the company would be sufficient to support its 2021 operations. The company shares are up ~12.0% in premarket.NovaBay focused on non-antibiotic anti-infective products also announce...

NovaBay Pharmaceuticals (NYSE American: NBY) issued the following Letter to Stockholders: To My Fellow Stockholders: NovaBay Pharmaceuticals enters 2021 focused on growing sales of our high-quality, differentiated consumer products: Avenova ® , the premier antimicro...

Gainers: Live Ventures (LIVE) +87%.GameStop (GME) +63%.Exela Technologies (XELA) +51%.AMMO (POWW) +41%.Castor Maritime (CTRM) +35%.Acorda Therapeutics (ACOR) +32%.Root (ROOT) +32%.Ondas Holdings (ONDS) +30%.NuCana (NCNA) +26%.Foresight Autonomous (FRSX) +26%.Losers:&#...

Gainers: Acorda Therapeutics (ACOR) +45%, NuCana (NCNA) +26%, Synlogic (SYBX) +24%, Evoke Pharma (EVOK) +23%, Tiziana Life Sciences (TLSA) +14%.Losers: Zomedica (ZOM) -26%, Forward Pharma (FWP) -15%, Provention Bio (PRVB) -14%, Acutu...

Marathon Patent Group MARA -19% after $250M capital raise.Zomedica (ZOM) -16%.Asia Pacific Wire & Cable Corporation (APWC) -16%.Harbor Custom Development HCDI -13% after pricing stock offering.Party City Holdco PRTY -12% after Q4 guidance falls short.Borr Dri...

NovaBay’s pure hypochlorous formulation safely eliminates 99.9% of viruses and bacteria on nonporous hard surfaces without cytotoxic chemicals NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY ) announces its proprietary hypochlorous acid solution h...

NovaBay Pharmaceuticals (NBY) perks 8% premarket after signing an agreement with Paragon Care Group Australia Pty Ltd for the exclusive distribution of Avenova in Australia.Paragon Care Group will begin distributing Avenova directly to consumers under its Designs For ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova ® for the eye care market, announces the signing of an agreement with Paragon Care Group Australia Pty Ltd for the exclusive distribution of Avenova ...